Natera (NTRA) reported Sunday its preliminary Q4 revenue increased 52% year over year to about $472 million.
Analysts surveyed by FactSet expect $417.4 million.
The company said roughly 792,800 tests were processed in Q4, compared with 626,800 tests a year earlier, marking an increase of 26.5%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments